title: Combination of mitoxantrone and etoposide in patients aged over 60 years with untreated acute myelogenous leukemia.
authors.affiliation: Department of Internal Medicine, University of Tübingen, FRG.
authors.forename: G
authors.initials: G
authors.lastname: Ehninger
authors.forename: E
authors.initials: E
authors.lastname: Fackler-Schwalbe
authors.forename: M
authors.initials: M
authors.lastname: Freund
authors.forename: G
authors.initials: G
authors.lastname: Heil
authors.forename: M
authors.initials: M
authors.lastname: Henke
authors.forename: D
authors.initials: D
authors.lastname: Hoelzer
authors.forename: R
authors.initials: R
authors.lastname: Hoffmann
authors.forename: E
authors.initials: E
authors.lastname: Kurrle
authors.forename: H
authors.initials: H
authors.lastname: Link
authors.forename: A
authors.initials: A
authors.lastname: Lösch
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy*; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D015337:Multicenter Studies as Topic
chemical_list: D005047:Etoposide; D008942:Mitoxantrone